fbpx Warning:
OSSIX® Plus must not be used in patients with known collagen hypersensitivity, sensitivity to porcine-derived materials, or suffer from autoimmune diseases and connective tissue diseases. As the membrane is of a collagen origin, allergic reactions may not be entirely excluded. Please read IFU before use and for additional information on indications, contraindications, warnings and precautions.text text
Menu

Volumetric Outcomes of Peri-implant Soft Tissue Augmentation with a Xenogeneic Cross-Linked Collagen Scaffold: A Comparative Clinical Study

Lorenzo Tavelli, Shayan Barootchi, Maria Vera Rodriguez, Priscila Ceolin Meneghetti, Gustavo Mendonça, Hom-Lay Wang

Int J Periodontics Restorative Dent. 2023 Jul-Aug;43(4):415-422.

This study assessed and compared the volumetric outcomes, from second-stage surgery to crown delivery, around implants that received STA with a xenogeneic cross-linked collagen scaffold (XCCS) vs nonaugmented implant site. XCCS-augmented implants showed significantly greater volumetric changes compared to control sites, which showed volume loss. STA with XCCS provided significantly greater volumetric outcomes compared to nonaugmented sites. 

Xenogeneic cross-linked collagen scaffold (XCCS) = OSSIX® Volumax

Read More

Contact Us

Please complete this form and a Datum Dental representative will contact you

    [recaptcha]





    Lets Talk

    Please fill in your details to download the requested brochure